Related Experiment Video
Updated: Mar 13, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Antipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe?
Unax Lertxundi1, Saioa Domingo-Echaburu1, Javier Peral1
1Dr. Lertxundi, Pharmacy Service, Red de Salud Mental de Araba, C/alava 43, Vitoria-Gasteiz, Araba, Spain. Dr. Domingo-Echaburu, Pharmacy Service, Hospital Alto Deba, Avda, Nafarroa, 16, Arrasate Gipuzkoa, Spain. Dr. Peral, Pharmacy Service, Hospital de Galdakao-Usánsolo, Barrio labeaga s/n, Galdakao, VIzcaya, Spain. Dr. García, Basque Country Pharmacovigilance Unit, Galdakao-Usansolo Hospital, Barrio labeaga s/n, Galdakao, VIzcaya, Spain.
Dopamine agonists can treat antipsychotic side effects like hyperprolactinemia in schizophrenia patients. While concerns exist about worsening psychosis, cabergoline may offer a safer alternative to bromocriptine, though further proof is needed.
Area of Science:
- Neuroscience
- Psychiatry
- Endocrinology
Background:
- Antipsychotic medications can cause hyperprolactinemia, a condition characterized by elevated prolactin levels.
- Dopamine agonists are known to reverse hyperprolactinemia but raise concerns about potentially worsening psychotic symptoms.
Conclusions:
- Dopamine agonists are a viable option for managing antipsychotic-induced hyperprolactinemia in schizophrenia.
- Further research is required to definitively establish whether cabergoline is safer than bromocriptine in this specific clinical context.
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis and Antipsychotic Drugs: Overview

